Specific inhibition of human CYP1A2 using a targeted antibody

Biochemical Pharmacology

Volumn 54, Issue 1, 1997, Pages 189-197

  Adams, Delyth A ^a   Edwards, Robert J ^a   Davies, Donald S ^a   Boobis, Alan R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antipeptide antibody; CYP1A2; Cytochrome P450; Human; Inhibition; Phenacetin O deethylase

Indexed keywords

CYTOCHROME P450; ENZYME ANTIBODY; ISOENZYME; SYNTHETIC PEPTIDE;

AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BINDING SITES; CYTOCHROME P-450 CYP1A2; ENZYME INHIBITORS; HUMANS; IMMUNE SERA; ISOENZYMES; MALE; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; RATS, WISTAR; SEQUENCE ALIGNMENT;

EID: 0030790040     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00167-6     Document Type: Article

References (46)

1. Porter TD and Coon MJ, Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266: 13469-13472, 1991.
2. Black SD and Coon MJ, P-450 cytochromes: Structure and function. Adv Enzymol Relat Areas Mol Biol 60: 35-87, 1987.
3. Murray M and Reidy GF, Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol Rev 42: 85-101, 1990.
4. Gelboin HV, Cytochrome P450 and monoclonal antibodies. Pharmacol Rev 45: 413-453, 1993.
5. Conney AH, Induction of microsomal cytochrome P-450 enzymes: The first Bernard B. Brodie lecture at Pennsylvania State University. Life Sci 39: 2493-2518, 1986.
6. Gooderham NJ, Murray S, Lynch AM, Edwards RJ, Yadollahi-Farsani M, Bratt C, Rich KJ, Zhao K, Murray BP, Bhadresa S, Crosbie SJ, Boobis AR and Davies DS, Heterocyclic amines: Evaluation of their role in diet associated human cancer. Br J Clin Pharmacol 42: 91-98, 1996.
7. Frey AB, Waxman DJ and Kreibich G, The structure of phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4. Production and characterization of site-specific antibodies. J Biol Chem 260: 15253-15265, 1985.
8. Edwards RJ, Singleton AM, Murray BP, Murray S, Boobis AR and Davies DS, Identification of a functionally conserved surface region of rat cytochromes P450IA. Biochem J 278: 749-757, 1991.
9. Edwards RJ, Singleton AM, Murray BP, Davies DS and Boobis AR, Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Biochem Pharmacol 49: 39-47, 1995.
10. Laurenzana EM, Sorrels SL and Owens SM, Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6. Drug Metab Dispos 23: 271-278, 1995.
11. Shen S and Strobel HW, Functional assessment of specific amino acid residues of cytochrome P4501A1 using anti-peptide antibodies. Arch Biochem Biophys 320: 162-169, 1995.
12. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O and Nebert DW, The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12: 1-51, 1993.
13. Edwards RJ, Singleton AM, Boobis AR and Davies DS, Cross-reaction of antibodies to coupling groups used in the production of anti-peptide antibodies. J Immunol Methods 117: 215-220, 1989.
14. Gonzalez FJ and Korzekwa KR, Cytochromes P450 expression systems. Annu Rev Pharmocol Toxicol 35: 369-390, 1995.
15. Edwards RJ, Singleton AM, Murray BP, Sesardic D, Rich KJ, Davies DS and Boobis AR, An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity. Biochem J 266: 497-504, 1990.
16. Boobis AR, Brodie MJ, Kahn GC, Fletcher DR, Saunders JH and Davies DS, Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol 9: 11-19, 1980.
17. Schulz-Schalge T, Heger W, Webb J, Kastner M and Neubert D, Ontogeny of monooxygenase activities in the marmoset monkey (Callithrix jacchus). J Med Primatol 20: 325-333, 1991.
18. Adamson RH, Thorgeirsson UP, Snyderwine EG, Thorgeirsson SS, Reeves J, Dalgard DW, Takayama S and Sugimura T, Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: Induction of tumors in three macaques. Jpn J Cancer Res 81: 10-14, 1990.
19. Edwards RJ, Singleton AM, Sesardic D, Boobis AR and Davies DS, Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat. Biochem Pharmacol 37: 3735-3741, 1988.
20. Jaiswal AK, Nebert DW and Gonzalez FJ, Human P3(450): cDNA and complete amino acid sequence. Nucleic Acids Res 14: 6773-6774, 1986.
21. Sogawa K, Gotoh O, Kawajiri K, Harada T and Fujii Kuriyama Y, Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450d) gene in the rat. J Biol Chem 260: 5026-5032, 1985.
22. Edwards RJ, Murray BP and Boobis AR, Anti-peptide antibodies in studies of cytochromes P450IA. Methods Enzymol 206: 220-233, 1991.
23. Edwards RJ, Murray BP, Murray S, Schulz T, Neubert D, Gant TW, Thorgeirsson SS, Boobis AR and Davies DS, Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis 15: 829-836, 1994.
24. Murray S and Boobis AR, An assay for paracetamol, produced by the O-deethylation of phenacetin in vitro, using gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom 13: 91-93, 1986.
25. Kahn GC, Boobis AR, Murray S, Brodie MJ and Davies DS, Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver. Br J Clin Pharmacol 13: 637-645, 1982.
26. Aitio A, A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 85: 488-491, 1978.
27. Edwards RJ, Murray BP, Singleton AM, Murray S, Davies DS and Boobis AR, Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man. Biochem Pharmacol 46: 213-220, 1993.
28. Murray BP, Edwards RJ, Murray S, Singleton AM, Davies DS and Boobis AR, Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis 14: 585-592, 1993.
29. Sesardic D, Boobis AR, Edwards RJ and Davies DS, A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol 26: 363-372, 1988.
30. Sesardic D, Edwards RJ, Davies DS, Thomas PE, Levin W and Boobis AR, High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat. Biochem Pharmacol 39: 489-498, 1990.
31. Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de-la-Torre R and Davies DS, Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol 29: 651-663, 1990.
32. Cheetham JC, Raleigh DP, Griest RE, Redfield C, Dobson CM and Rees AR, Antigen mobility in the combining site of an anti-peptide antibody. Proc Natl Acad Sci USA 88: 7968-7972, 1991.
33. Dyrberg T and Oldstone MB, Peptides as antigens. Importance of orientation. J Exp Med 164: 1344-1349, 1986.
34. Lipkin WI, Schwimmbeck PL and Oldstone MB, Antibody to synthetic somatostatin-28(1-12): Immunoreactivity with somatostatin in brain is dependent on orientation of immunizing peptide. J Histochem Cytochem 36: 447-451, 1988.
35. Schaaper WM, Lankhof H, Puijk WC and Meloen RH, Manipulation of antipeptide immune response by varying the coupling of the peptide with the carrier protein. Mol Immunol 26: 81-85, 1989.
36. Edwards RJ, Murray BP, Boobis AR and Davies DS, Identification and location of alpha-helices in mammalian cytochromes P450. Biochemistry 28: 3762-3770, 1989.
37. Gueguen M, Boniface O, Bernard O, Clerc F, Cartwright T and Alvarez F, Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody. J Autoimmun 4: 607-615, 1991.
38. Manns MP, Griffin KJ, Sullivan KF and Johnson EF, LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 88: 1370-1378, 1991.
39. Murray BP, Edwards RJ, Davies DS and Boobis AR, Conservation of a functionally important surface region between two families of the cytochrome P-450 superfamily. Biochem J 292: 309-310, 1993.
40. Poulos TL, Finzel BC and Howard AJ, High-resolution crystal structure of cytochrome P450cam. J Mol Biol 195: 687-700, 1987.
41. Boddupalli SS, Hasemann CA, Ravichandran KG, Lu JY, Goldsmith EJ, Deisenhofer J and Peterson JA, Crystallization and preliminary x-ray diffraction analysis of P450terp and the hemoprotein domain of P450BM-3, enzymes belonging to two distinct classes of the cytochrome P450 superfamily. Proc Natl Acad Sci USA 89: 5567-5571, 1992.
42. Sakuma T, Hieda M, Igarashi T, Ohgiya S, Isogai M, Nimomiya S, Nagata R and Kamataki T, Cloning and expression of cynomolgus monkey and marmoset CYP1A2: Capability to activate carcinogenic heterocyclic amines. XIth International Symposium on Microsomes and Drug Oxidations, University of California at Los Angeles, USA Abstract P-235, 1996.
43. Kimura S, Gonzalez FJ and Nebert DW, The murine Ah locus. Comparison of the complete cytochrome P1-450 and P3-450 cDNA nucleotide and amino acid sequences. J Biol Chem 259: 10705-10713, 1984.
44. Turesky RJ, Gross GA, Stillwell WG, Skipper PL and Tannenbaum SR, Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring. Environ Health Perspect 102: 47-51, 1994.
45. Ozols J, Complete amino acid sequence of a cytochrome P-450 isolated from beta-naphthoflavone-induced rabbit liver microsomes. Comparison with phenobarbital-induced and constitutive isozymes and identification of invariant residues. J Biol Chem 261: 3965-3979, 1986.
46. Lai TS and Chiang JY, Cloning and characterization of two major 3-methylcholanthrene inducible hamster liver cytochrome P450s. Arch Biochem Biophys 283: 429-439, 1990.